ANI Pharmaceuticals, Inc. (ANIP) Q4 2023 Earnings Call

Investor webinar replay

Replay transcript excerpt

Good day, everyone, and welcome to today's A&I Pharmaceuticals, Inc., fourth quarter 2023 earnings results call. At this time, all participants are in a listen-only mode. Later, you will have the opportunity to ask questions during the question and answer session. You may register to ask a question at any time by pressing star 1 on your telephone keypad. You may withdraw yourself from the queue by pressing star 2. Please note this call is being recorded. I will be standing by if you should need any assistance. It is now my pleasure to turn the conference over to Judy DiClemente, Investor Relations for A&I Pharmaceuticals. Thank you, Angela. Welcome to A&I Pharmaceuticals Q4 2023 earnings call. This is Judy DiClemente of Insight Communications, Investor Relations for A&I. With me on today's call are Nikhil Lalwani, President and Chief Executive Officer, and Stephen Carey, Chief Financial Officer. You can also access the webcast of this call to the investor section of the A&I website at www.anifarmaceuticals.com. Before we get started, I would like to remind everyone that any statements made on today's conference call that express a belief, expectation, projection, forecast, anticipation, or intent regarding future events and the company's future performance may be considered forward-looking statements as defined by the Private Securities Litigation Reform Act. These forward-looking statements are based on information available to A&I Pharmaceuticals Management as of today and involve risks and uncertainties, including those noted in our press release issued this morning and our filings with the SEC. But forward-looking statements are not guarantees of future performance. Actual results may differ materially from those projected in the forward-looking statements. ANI s...